• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Sanofi-Aventis ADR

Sanofi-Aventis ADR

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Regeneron and Sanofi Announce Positive Topline Results from Phase 3 Studies with Sarilumab in Patients with Rheumatoid Arthritis

    Regeneron and Sanofi Announce Positive Topline Results from Phase 3 Studies with Sarilumab in Patients with Rheumatoid Arthritis

  2. Sanofi, Regeneron Seek US Approval for Rheumatoid Arthritis Drug

    Sanofi, Regeneron Seek US Approval for Rheumatoid Arthritis Drug

  3. Rentrak Announces Official Worldwide Box Office Results for Weekend of May 17, 2015

    Rentrak Announces Official Worldwide Box Office Results for Weekend of May 17, 2015

  4. Regeneron and Sanofi Announce Positive Pivotal Phase 2b Dupilumab Data in Asthma Presented at the American Thoracic Society 2015 International Conference

    Regeneron and Sanofi Announce Positive Pivotal Phase 2b Dupilumab Data in Asthma Presented at the American Thoracic Society 2015 International Conference

  5. Rentrak Announces Official Worldwide Box Office Results for Weekend of May 10, 2015

    Rentrak Announces Official Worldwide Box Office Results for Weekend of May 10, 2015

  6. Rentrak Announces Official Worldwide Box Office Results for Weekend of May 3, 2015

    Rentrak Announces Official Worldwide Box Office Results for Weekend of May 3, 2015

  7. Generic Drugs Grab Growing Market Share in Mexico--Update

    Generic Drugs Grab Growing Market Share in Mexico--Update

  8. Generic Drugs Grab Market Share in Mexico

    Generic Drugs Grab Market Share in Mexico

  9. Funds That Buy Like Buffett 2015

    Funds that emulate the Oracle of Omaha have done well over time.

  10. Novo Nordisk Records Growth in Net Profit -- Update

    Novo Nordisk Records Growth in Net Profit -- Update

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.